ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for CAPVAXIVE®:MSD Merck Sharp & Dohme AG
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Stand der Information

Juni 2025
V116-I-OMA-RCN000026079-RCN000027402-CH
Revisions-Historie
2024-09-06-Advisory 01 received; 08.10.2024 Advisory 02 to add P008 received; 31.10.2024 submitted to SHI; LoQ received 04.02.2025; Advisory 03 received 07.03.2025; RtQ submitted 21.03.2025;PD received June 13 2025; Advisory 04 received July 09; rPD submitted July 31; informal labelling comments received 12.09.2025; Advisory received 15.09.2025 (all changes accepted); approval received 23.09.2025;

2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home